C-reactive protein: from acute phase reactant to cardiovascular disease risk factor.
Woodhouse
Sherry
S
Division of Pathology and Laboratory Medicine, Cleveland Clinic Florida, Weston, FL, USA.
D000209:Acute-Phase Proteins / Q000009:adverse effects / Q000378:metabolism; D000789:Angina, Unstable / Q000209:etiology / Q000378:metabolism; D001161:Arteriosclerosis / Q000209:etiology / Q000378:metabolism / Q000517:prevention & control; D002097:C-Reactive Protein / Q000009:adverse effects / Q000378:metabolism*; D002318:Cardiovascular Diseases / Q000453:epidemiology / Q000209:etiology / Q000378:metabolism* / Q000517:prevention & control; D008078:Cholesterol, LDL / Q000009:adverse effects; D004496:Education, Continuing; D006801:Humans; D008148:Lovastatin / Q000627:therapeutic use; D017056:Medical Laboratory Personnel / Q000193:education; D012307:Risk Factors; D014481:United States / Q000453:epidemiology
D000209:Acute-Phase Proteins; D008078:Cholesterol, LDL; D002097:C-Reactive Protein; D008148:Lovastatin